Growing preference for computer
aided diagnosis to drive the growth of global digital pathology market
According to
TechSci Research report, “Global Digital
Pathology Market By Component (Software, Scanner, Services), By Technology
(Whole Slide Imaging, Storage, Communication & Integrated Platforms, Image
Analysis-Informatics, Others), By Type (Human v/s Veterinary), By Application
(Drug Discovery, Disease Diagnosis, Teleconsultation, Training & Education,
Others), By End Users (Hospitals & Clinics, Biotechnology & Pharmaceutical
Companies, Research Laboratories, Contract Research Organizations, Others), By
Region, Forecast & Opportunities, 2025”, the global
digital pathology market is expected to grow at a formidable rate during the
forecast period on account of the increasing adoption of digital pathology to
enhance the lab efficiency. Additionally, digital pathology offers scrutiny and
analysis of images on computer, high resolution sample screening and online
storage of digital slides which enables the pathologists to cross examine the
slides without any physical evidence. Furthermore, growing application of
digital pathology in drug discovery and development is fostering the growth of
market, globally. Moreover, benefits such as ease of virtual transportation of
slides and high efficiency of the technique positively impacts the growth of
market. However, lack of trained and skilled pathologists can hamper the growth
of market during forecast period. Also, lack of adoption and use of this
technique over the conventional ones might negatively impact the market growth.
Moreover, high cost of software and scanners might further restrict the growth
of market over the next few years.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on " Global Digital Pathology Market"
The global
digital pathology market is segmented based on component, technology, type,
application, end user, company and region. Based on component, the market can
be categorized into software, scanner and services. The scanners are expected
to dominate the market over the next few years owing to the benefits offered by
them such as assistance in analyzing multitude of images with ease and help in
studying morphologies and images. Additionally, growing adoption of digital pathology around
the globe and recent regulatory approvals grants by the FDA are further anticipated
to drive the growth of segment through 2025. Based on type, the market can be
bifurcated into human and veterinary. The human segment is expected to dominate
the market owing to the growing prevalence of chronic diseases such as cancer,
cardiac disorder, diabetes, renal disorders, among others. Based on
application, the market can be grouped into drug discovery, disease diagnosis,
teleconsultation, training & education and others. The disease diagnosis is
expected to hold the largest market share over the next few years on account of
the increase in number of patients suffering from chronic diseases, while the
teleconsultation segment is expected to grow due to increase in geriatric
population suffering from various diseases. Based on end user, the market can
be fragmented into hospitals & clinics, biotechnology & pharmaceutical
companies, research laboratories, contract research organizations and others.
The biotechnology & pharmaceutical companies are expected to register the
highest CAGR in the market on account of the increasing use of digital
pathology for drug discovery studies and drug toxicology testing. Additionally,
they deliver well organized, documented, retrieved and logistical pathological
procedures.
Leica
Biosystems, Koninklijke Philips N.V., Hamamatsu Photonics, F. Hoffmann-La Roche
AG, 3DHISTECH, Apollo Enterprise Imaging, XIFIN, Huron Digital Pathology,
Visiopharm A/S, Corista, Indica Labs, Objective Pathology Services, Sectra AB,
OptraSCAN, Glencoe Software, KONFOONG BIOTECH INTERNATIONAL CO., LTD,
Inspirata, Inc., Mikroscan Technologies, Proscia Inc., Kanteron Systems and
others are some of the leading players operating in global digital pathology market.
The companies operating in the market are using organic strategies such as
product launches, mergers and collaborations to boost their share. For
instance, in 2018, F. Hoffmann-La Roche AG launched VENTANA DP 200, a high
speed slide scanner for digital pathology. The scanner can produce high quality
images attributable to its tray based design.
Customers can
also request for 10% free customization on this report.
“Asia-Pacific is expected to
witness significant growth in the digital pathology market during the forecast
period, owing to the increasing awareness related to digital pathology systems
in the region. Additionally, increasing number of people suffering from chronic
diseases such as cancer, diabetes, cardiovascular diseases, among others in the
region is further anticipated to spur the market through 2025. Furthermore,
increasing healthcare expenditure coupled with improving healthcare IT
infrastructure in the region is expected to create lucrative opportunities for
the players in market over the next few years.” said Mr. Karan Chechi, Research
Director with TechSci Research, a research based global management consulting
firm.
“Global Digital Pathology Market By Component
(Software, Scanner, Services), By Technology (Whole Slide Imaging, Storage,
Communication & Integrated Platforms, Image Analysis-Informatics, Others), By
Type (Human v/s Veterinary), By Application (Drug Discovery, Disease Diagnosis,
Teleconsultation, Training & Education, Others), By End Users (Hospitals
& Clinics, Biotechnology & Pharmaceutical Companies, Research
Laboratories, Contract Research Organizations, Others), By Region, Forecast
& Opportunities, 2025”, has evaluated
the future growth potential of global digital pathology market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in global digital pathology market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
No comments:
Post a Comment